The World Market for Medicaments Containing Antibiotics or Their Derivatives: A 2009 Global Trade Perspective
ICON Group International, January 2009, Pages: 246
This report was created for strategic planners, international executives and import/export managers who are concerned with the market for medicaments containing antibiotics or their derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for medicaments containing antibiotics or their derivatives for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying medicaments containing antibiotics or their derivatives? What is the dollar value of these imports? How much do the imports of medicaments containing antibiotics or their derivatives vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of medicaments containing antibiotics or their derivatives? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported medicaments containing antibiotics or their derivatives. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of medicaments containing antibiotics or their derivatives, for each individual country. Chapter 4 does the same, but for imports of medicaments containing antibiotics or their derivatives for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of medicaments containing antibiotics or their derivatives to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in medicaments containing antibiotics or their derivatives (i.e. their market shares are close or equal to zero percent). "Medicaments Containing Antibiotics or Their Derivatives" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "medicaments containing antibiotics or their derivatives" is 5421 . For more information on this definition, please refer to the following web site:
http://unstats.un.org/unsd/cr/registry/regcs.asp?Cl=14&Lg=1&Co=542 .
Important Caveat. The figures should be seen as market estimates, as opposed to historical records, as these are forecasted for the current year of trade. More importantly, in light of the fact that unforeseeable factors might interrupt markets in achieving their reported levels, the figures should be seen as estimates of potential. For example, "mad cow" disease, foot-and-mouth disease, trade embargoes, labor disputes, military conflicts, acts of terrorism and other events will certainly affect the actual trade flows recorded for a variety of industry or product categories. In such cases, the difference between the numbers given in this report and the numbers actually observed might be interpreted as the "net loss" or "net gain" due to these exogenous events affecting regular trade flows that would have occurred had these events not have taken place.
Related Reports. This report was created for the market for medicaments containing antibiotics or their derivatives. Closely related reports published by ICON Group include the following:
The World Market for Antibiotics Excluding Medicaments: A 2009 Global Trade Perspective
The World Market for Ephedrines and Their Salts: A 2009 Global Trade Perspective
The World Market for Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products: A 2009 Global Trade Perspective
The World Market for Medicaments Containing Antibiotics or Their Derivatives: A 2009 Global Trade Perspective
The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives: A 2009 Global Trade Perspective
The World Market for Natural or Synthetic Hormones, Hormone Derivatives, and Other Steriods Used as Hormones Excluding Medicaments: A 2009 Global Trade Perspective
The World Market for Pharmaceutical Goods Excluding Medicaments: A 2009 Global Trade Perspective
The World Market for Provitamins and Vitamins Excluding Medicaments: A 2009 Global Trade Perspective
The World Market for Rye Ergot Alkaloids, Their Derivatives, and Salts Thereof: A 2009 Global Trade Perspective
The World Market for Vegetable Alkaloids and Their Salts, Ethers, Esters and Other Derivatives Excluding Medicaments: A 2009 Global Trade Perspective
1 METHODOLOGY 11
1.1 Our Approach 11
2 THE WORLD MARKET 14
2.1 Exports 14
2.1.1 The World Market: Medicaments Containing Antibiotics or Their Derivatives Export Supplies in 2009 14
2.2 Imports 16
2.2.1 The World Market: Imported Medicaments Containing Antibiotics or Their Derivatives in 2009 16
3 EXPORTS 20
3.1 Africa: Export Supplies of Medicaments Containing Antibiotics or Their Derivatives 20
3.1.1 Executive Summary 20
3.1.2 Egypt 23
3.1.3 Ethiopia 24
3.1.4 Ghana 24
3.1.5 Kenya 24
3.1.6 Libya 25
3.1.7 Mauritius 25
3.1.8 Morocco 25
3.1.9 Senegal 26
3.1.10 Sierra Leone 26
3.1.11 South Africa 27
3.1.12 Swaziland 27
3.1.13 Tanzania 27
3.1.14 Togo 28
3.1.15 Tunisia 28
3.1.16 Zimbabwe 28
3.2 Asia: Export Supplies of Medicaments Containing Antibiotics or Their Derivatives 28
3.2.1 Executive Summary 28
3.2.2 Bangladesh 31
3.2.3 China 32
3.2.4 Hong Kong 33
3.2.5 India 34
3.2.6 Indonesia 35
3.2.7 Japan 36
3.2.8 Macau 37
3.2.9 Malaysia 37
3.2.10 North Korea 38
3.2.11 Philippines 38
3.2.12 Singapore 39
3.2.13 South Korea 40
3.2.14 Sri Lanka 41
3.2.15 Taiwan 41
3.2.16 Thailand 42
3.2.17 Vietnam 42
3.3 Europe: Export Supplies of Medicaments Containing Antibiotics or Their Derivatives 43
3.3.1 Executive Summary 43
3.3.2 Austria 47
3.3.3 Belarus 48
3.3.4 Belgium 49
3.3.5 Bosnia and Herzegovina 50
3.3.6 Bulgaria 51
3.3.7 Croatia 52
3.3.8 Cyprus 53
3.3.9 Czech Republic 54
3.3.10 Denmark 55
3.3.11 Estonia 56
3.3.12 Finland 56
3.3.13 France 57
3.3.14 Georgia 58
3.3.15 Germany 59
3.3.16 Greece 60
3.3.17 Hungary 61
3.3.18 Iceland 62
3.3.19 Ireland 63
3.3.20 Italy 64
3.3.21 Kazakhstan 65
3.3.22 Latvia 65
3.3.23 Lithuania 65
3.3.24 Luxembourg 66
3.3.25 Macedonia 66
3.3.26 Malta 66
3.3.27 Moldova 67
3.3.28 Norway 68
3.3.29 Poland 69
3.3.30 Portugal 70
3.3.31 Romania 71
3.3.32 Russia 71
3.3.33 Serbia and Montenegro 72
3.3.34 Slovakia 72
3.3.35 Slovenia 73
3.3.36 Spain 74
3.3.37 Sweden 75
3.3.38 Switzerland 76
3.3.39 the Netherlands 77
3.3.40 the United Kingdom 78
3.3.41 Ukraine 79
3.4 Latin America: Export Supplies of Medicaments Containing Antibiotics or Their Derivatives 79
3.4.1 Executive Summary 79
3.4.2 Argentina 83
3.4.3 Bolivia 83
3.4.4 Brazil 84
3.4.5 Chile 85
3.4.6 Colombia 85
3.4.7 Costa Rica 86
3.4.8 Ecuador 86
3.4.9 El Salvador 87
3.4.10 Guatemala 87
3.4.11 Honduras 87
3.4.12 Mexico 88
3.4.13 Panama 89
3.4.14 Paraguay 89
3.4.15 Peru 90
3.4.16 Uruguay 90
3.4.17 Venezuela 91
3.5 North America & the Caribbean: Export Supplies of Medicaments Containing Antibiotics or Their Derivatives 91
3.5.1 Executive Summary 91
3.5.2 Aruba 94
3.5.3 Barbados 94
3.5.4 Bermuda 94
3.5.5 Canada 95
3.5.6 Cuba 96
3.5.7 Dominican Republic 96
3.5.8 St. Kitts and Nevis 96
3.5.9 the Netherlands Antilles 97
3.5.10 the United States 98
3.6 Oceana: Export Supplies of Medicaments Containing Antibiotics or Their Derivatives 99
3.6.1 Executive Summary 99
3.6.2 Australia 102
3.6.3 New Zealand 103
3.6.4 the Pitcairn Islands 103
3.7 the Middle East: Export Supplies of Medicaments Containing Antibiotics or Their Derivatives 104
3.7.1 Executive Summary 104
3.7.2 Afghanistan 106
3.7.3 Iran 106
3.7.4 Israel 107
3.7.5 Jordan 108
3.7.6 Kuwait 108
3.7.7 Lebanon 109
3.7.8 Oman 109
3.7.9 Pakistan 109
3.7.10 Saudi Arabia 110
3.7.11 Syrian Arab Republic 110
3.7.12 Tajikistan 110
3.7.13 the United Arab Emirates 111
3.7.14 Turkey 112
4 IMPORTS 113
4.1 Africa: Medicaments Containing Antibiotics or Their Derivatives Imports in 2009 113
4.1.1 Executive Summary 113
4.1.2 Algeria 117
4.1.3 Benin 118
4.1.4 Burkina Faso 118
4.1.5 Burundi 118
4.1.6 Cameroon 119
4.1.7 Cape Verde 119
4.1.8 Egypt 120
4.1.9 Gabon 120
4.1.10 Kenya 121
4.1.11 Madagascar 122
4.1.12 Malawi 122
4.1.13 Mauritius 123
4.1.14 Morocco 124
4.1.15 Senegal 125
4.1.16 South Africa 126
4.1.17 Sudan 127
4.1.18 Tanzania 128
4.1.19 the Gambia 128
4.1.20 Togo 129
4.1.21 Tunisia 129
4.1.22 Uganda 130
4.1.23 Zambia 130
4.1.24 Zimbabwe 131
4.2 Asia: Medicaments Containing Antibiotics or Their Derivatives Imports in 2009 131
4.2.1 Executive Summary 131
4.2.2 Bangladesh 134
4.2.3 Cambodia 135
4.2.4 China 136
4.2.5 Hong Kong 137
4.2.6 India 138
4.2.7 Indonesia 139
4.2.8 Japan 140
4.2.9 Macau 141
4.2.10 Malaysia 142
4.2.11 Maldives 143
4.2.12 Mongolia 143
4.2.13 Philippines 144
4.2.14 Singapore 145
4.2.15 South Korea 146
4.2.16 Sri Lanka 147
4.2.17 Taiwan 148
4.2.18 Thailand 149
4.3 Europe: Medicaments Containing Antibiotics or Their Derivatives Imports in 2009 150
4.3.1 Executive Summary 150
4.3.2 Albania 154
4.3.3 Andorra 155
4.3.4 Austria 156
4.3.5 Belarus 157
4.3.6 Belgium 158
4.3.7 Bosnia and Herzegovina 159
4.3.8 Bulgaria 160
4.3.9 Croatia 161
4.3.10 Cyprus 162
4.3.11 Czech Republic 163
4.3.12 Denmark 164
4.3.13 Estonia 165
4.3.14 Finland 166
4.3.15 France 167
4.3.16 Georgia 168
4.3.17 Germany 169
4.3.18 Greece 170
4.3.19 Hungary 171
4.3.20 Iceland 172
4.3.21 Ireland 173
4.3.22 Italy 174
4.3.23 Latvia 175
4.3.24 Lithuania 176
4.3.25 Luxembourg 177
4.3.26 Macedonia 177
4.3.27 Malta 178
4.3.28 Moldova 179
4.3.29 Norway 180
4.3.30 Poland 181
4.3.31 Portugal 182
4.3.32 Romania 183
4.3.33 Russia 184
4.3.34 Serbia and Montenegro 185
4.3.35 Slovakia 186
4.3.36 Slovenia 187
4.3.37 Spain 188
4.3.38 Sweden 189
4.3.39 Switzerland 190
4.3.40 the Faroe Islands 191
4.3.41 the Netherlands 192
4.3.42 the United Kingdom 193
4.3.43 Ukraine 194
4.4 Latin America: Medicaments Containing Antibiotics or Their Derivatives Imports in 2009 195
4.4.1 Executive Summary 195
4.4.2 Argentina 199
4.4.3 Bolivia 200
4.4.4 Brazil 201
4.4.5 Chile 202
4.4.6 Colombia 203
4.4.7 Costa Rica 204
4.4.8 Ecuador 205
4.4.9 El Salvador 206
4.4.10 Guatemala 207
4.4.11 Guyana 208
4.4.12 Mexico 209
4.4.13 Nicaragua 210
4.4.14 Paraguay 211
4.4.15 Peru 212
4.4.16 Uruguay 213
4.4.17 Venezuela 214
4.5 North America & the Caribbean: Medicaments Containing Antibiotics or Their Derivatives Imports in 2009 215
4.5.1 Executive Summary 215
4.5.2 Barbados 217
4.5.3 Canada 218
4.5.4 St. Lucia 219
4.5.5 St. Vincent and the Grenadines 219
4.5.6 the United States 220
4.5.7 Trinidad and Tobago 221
4.6 Oceana: Medicaments Containing Antibiotics or Their Derivatives Imports in 2009 221
4.6.1 Executive Summary 221
4.6.2 Australia 225
4.6.3 Fiji 226
4.6.4 New Caledonia 226
4.6.5 New Zealand 227
4.7 the Middle East: Medicaments Containing Antibiotics or Their Derivatives Imports in 2009 227
4.7.1 Executive Summary 227
4.7.2 Armenia 230
4.7.3 Azerbaijan 231
4.7.4 Bahrain 232
4.7.5 Iran 233
4.7.6 Israel 234
4.7.7 Jordan 235
4.7.8 Kyrgyzstan 236
4.7.9 Lebanon 237
4.7.10 Oman 238
4.7.11 Pakistan 239
4.7.12 Qatar 240
4.7.13 Saudi Arabia 241
4.7.14 Syrian Arab Republic 242
4.7.15 Turkey 243
4.7.16 Yemen 244
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 245
5.1 Disclaimers & Safe Harbor 245
5.2 ICON Group Ltd. User Agreement Provisions 246
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
